Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models

by Julie Bigarreau, Nathalie Rouach, Anselme L. Perrier, Franck Mouthon, Mathieu Charvériat
Published 2022-01-01

Connexin-Dependent Neuroglial Networking as a New Therapeutic Target

by Mathieu Charvériat, Christian C. Naus, Luc Leybaert, Juan C. Sáez, Juan C. Sáez, Christian Giaume
Published 2017-06-01

Impaired Local and Long-Range Brain Connectivity and Visual Response in a Genetic Rat Model of Hyperactivity Revealed by Functional Ultrasound

by Marine Droguerre, Benjamin Vidal, Benjamin Vidal, Marco Valdebenito, Franck Mouthon, Luc Zimmer, Luc Zimmer, Luc Zimmer, Mathieu Charvériat
Published 2022-03-01

Upregulation of astroglial connexin 30 impairs hippocampal synaptic activity and recognition memory

by Eléonore Hardy, Julien Moulard, Augustin Walter, Pascal Ezan, Alexis-Pierre Bemelmans, Franck Mouthon, Mathieu Charvériat, Nathalie Rouach, Armelle Rancillac
Published 2023-04-01

Upregulation of astroglial connexin 30 impairs hippocampal synaptic activity and recognition memory.

by Eléonore Hardy, Julien Moulard, Augustin Walter, Pascal Ezan, Alexis-Pierre Bemelmans, Franck Mouthon, Mathieu Charvériat, Nathalie Rouach, Armelle Rancillac
Published 2023-04-01

Pharmaco-fUS for Characterizing Drugs for Alzheimer’s Disease – The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine

by Benjamin Vidal, Benjamin Vidal, Marine Droguerre, Marco Valdebenito, Luc Zimmer, Luc Zimmer, Luc Zimmer, Michel Hamon, Franck Mouthon, Mathieu Charvériat
Published 2020-08-01

Impact of Donepezil on Brain Glucose Metabolism Assessed Using [18F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer’s Disease Induced...

by Gaëlle Hugon, Sébastien Goutal, Marie Sarazin, Marie Sarazin, Marie Sarazin, Michel Bottlaender, Michel Bottlaender, Fabien Caillé, Marine Droguerre, Mathieu Charvériat, Alexandra Winkeler, Nicolas Tournier
Published 2022-02-01

Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer’s Disease

by Marine Droguerre, Adeline Duchêne, Christèle Picoli, Benjamin Portal, Camille Lejards, Bruno P. Guiard, Johann Meunier, Vanessa Villard, Nicole Déglon, Nicole Déglon, Michel Hamon, Franck Mouthon, Mathieu Charvériat
Published 2020-06-01